We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-6.43%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.88B
AUM Growth
-$383M
(-7.3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
934
New
138
Increased
293
Reduced
289
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$40.2M |
| 2 |
Eli Lilly
LLY
|
+$37M |
| 3 |
PepsiCo
PEP
|
+$29.9M |
| 4 |
Wells Fargo
WFC
|
+$19M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$27.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$25.7M |
| 3 |
ExxonMobil
XOM
|
+$23.1M |
| 4 |
Costco
COST
|
+$22.1M |
| 5 |
Paychex
PAYX
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.87% |
| 2 | Healthcare | 16.79% |
| 3 | Technology | 16.66% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Rigel Pharmaceuticals
RIGL
$680M
| $1.88M | 0.04% |
76,249
+9,700
| +15% | +$289K |
|
|
LNKD
377
DELISTED
LinkedIn Corporation
LNKD
| $1.85M | 0.04% |
9,750
-10,764
| -52% | -$2.14M |
|
378
Jones Lang LaSalle
JLL
$15.1B
| $1.84M | 0.04% |
12,809
+2,074
| +19% | +$339K |
|
379
Quad
QUAD
$430M
| $1.84M | 0.04% |
152,070
-33,400
| -18% | -$507K |
|
|
AVID
380
DELISTED
Avid Technology Inc
AVID
| $1.82M | 0.04% |
228,333
+62,000
| +37% | +$637K |
|
|
CLGX
381
DELISTED
Corelogic, Inc.
CLGX
| $1.79M | 0.04% |
47,990
+40,020
| +502% | +$1.55M |
|
|
ARGO
382
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.78M | 0.04% |
+39,909
| New | +$1.77M |
|
383
American Eagle Outfitters
AEO
$2.85B
| $1.78M | 0.04% |
114,170
-166,770
| -59% | -$2.85M |
|
|
RTEC
384
DELISTED
Rudolph Technologies Inc
RTEC
| $1.77M | 0.04% |
141,941
+21,570
| +18% | +$265K |
|
385
Children's Place
PLCE
$53.6M
| $1.75M | 0.04% |
30,426
+25,566
| +526% | +$1.54M |
|
386
Labcorp
LH
$24.3B
| $1.75M | 0.04% |
18,771
| – | – |
|
387
ServiceNow
NOW
$102B
| $1.75M | 0.04% |
125,810
-313,200
| -71% | -$4.68M |
|
|
LHO
388
DELISTED
LaSalle Hotel Properties
LHO
| $1.72M | 0.04% |
60,640
-20,460
| -25% | -$674K |
|
|
NAVG
389
DELISTED
Navigators Group Inc
NAVG
| $1.71M | 0.04% |
43,870
+22,800
| +108% | +$886K |
|
390
CF Industries
CF
$19.2B
| $1.7M | 0.03% |
37,900
-1,005
| -3% | -$58.4K |
|
391
Capital One
COF
$124B
| $1.7M | 0.03% |
23,390
-11,020
| -32% | -$885K |
|
|
GWB
392
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.7M | 0.03% |
+66,840
| New | +$1.68M |
|
393
Emergent Biosolutions
EBS
$375M
| $1.68M | 0.03% |
58,903
-47,170
| -44% | -$1.55M |
|
|
SHOR
394
DELISTED
ShoreTel, Inc.
SHOR
| $1.67M | 0.03% |
223,936
-18,100
| -7% | -$130K |
|
|
HAWK
395
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.67M | 0.03% |
39,310
-500
| -1% | -$21.3K |
|
|
TOWR
396
DELISTED
Tower International, Inc.
TOWR
| $1.64M | 0.03% |
69,130
+19,790
| +40% | +$505K |
|
|
SHLM
397
DELISTED
Schulman (A.) Inc
SHLM
| $1.63M | 0.03% |
50,330
+33,760
| +204% | +$1.19M |
|
398
Insight Enterprises
NSIT
$3.55B
| $1.62M | 0.03% |
62,539
+43,000
| +220% | +$1.14M |
|
399
Kulicke & Soffa
KLIC
$5.3B
| $1.6M | 0.03% |
174,274
+143,363
| +464% | +$1.48M |
|
400
Nelnet
NNI
$4.79B
| $1.6M | 0.03% |
+46,120
| New | +$1.82M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2015 Portfolio in Review
As of Q3 2015, Jacobs Levy Equity Management held 934 positions worth $4.88B, down 7.3% from $5.26B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q3 2015 filing shows 138 new, 293 increased, 289 reduced and 135 closed positions. Its largest new stake was Accenture: 404,880 shares worth $39.8M. The largest sale was Du Pont De Nemours E I, an estimated $27.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
- Jacobs Levy Equity Management's largest Q3 2015 buy was Accenture: 404,880 shares worth $39.8M.
- Jacobs Levy Equity Management added most to Eli Lilly in Q3 2015, an estimated $37M increase.
- Jacobs Levy Equity Management's biggest Q3 2015 reduction was Du Pont De Nemours E I, cutting an estimated $27.6M.
- Jacobs Levy Equity Management fully exited HEALTH NET INC in Q3 2015, selling an estimated $16M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.88B portfolio in Q3 2015.
- Jacobs Levy Equity Management opened 138 new positions and closed 135 in Q3 2015.
- Jacobs Levy Equity Management's portfolio value fell 7.3% quarter-over-quarter to $4.88B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2015, filed 16 Nov 2015.